VanEck Biotech ETFBBH
BBH
0
Funds holding %
of 6,809 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
0% more funds holding
Funds holding: 113 [Q2] → 113 (+0) [Q3]
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
2% less capital invested
Capital invested by funds: $154M [Q2] → $151M (-$2.96M) [Q3]
26.21% less ownership
Funds ownership: 104.5% [Q2] → 78.3% (-26.21%) [Q3]
29% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 28
Research analyst outlook
We haven’t received any recent analyst ratings for BBH.
Financial journalist opinion
Neutral
Business Wire
2 days ago
VanEck Announces Year-End Distributions for VanEck Equity ETFs
NEW YORK--(BUSINESS WIRE)--VanEck has announced the 2024 annual distributions per share for its VanEck equity exchange-traded funds (ETFs).
Neutral
Zacks Investment Research
2 months ago
Should You Invest in the VanEck Biotech ETF (BBH)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011.
Neutral
Zacks Investment Research
4 months ago
Should You Invest in the VanEck Biotech ETF (BBH)?
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
Positive
Seeking Alpha
5 months ago
BBH: Buy Rating, As Tech Investors Look Beyond FAANG
Biotechnology sector experiencing exponential growth driven by emerging technologies addressing global challenges. VanEck Biotech ETF tracks top U.S.-listed biotech companies, offers exposure to innovative therapies and technologies. BBH is under-discovered compared to peers, offers potential for trend change in favor of biotech sector.
Positive
InvestorPlace
5 months ago
Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for June 2024
I'm on the hunt for ‘Strong Buy' biotech stocks. According to Finviz.com, there are 680 U.S.-listed biotech stocks.
Positive
Zacks Investment Research
5 months ago
Biotech ETF (BBH) Hits New 52-Week High
VanEck Biotech ETF BBH is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and moved up 21.4% from its 52-week low price of $142.51/share.
Neutral
Zacks Investment Research
6 months ago
Should You Invest in the VanEck Biotech ETF (BBH)?
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the VanEck Biotech ETF (BBH), a passively managed exchange traded fund launched on 12/20/2011.
Neutral
Business Wire
7 months ago
ETF Investors Indicate Active Strategies and Product Innovation Will Fuel the Industry's Continued Growth: BBH 2024 Global ETF Investor Survey
BOSTON--(BUSINESS WIRE)--As the ETF industry reaches a milestone of $12.71 trillion in global assets, the Brown Brothers Harriman 2024 Global ETF Investor Survey finds that investors plan to further increase their use of ETFs in the next year, while also expanding the number of ETF providers they invest with. Active ETFs, which have grown at a staggering 38.4%i annual rate over the past 10 years, will continue to be a focus for ETF investors as they seek downside protection while pursuing new a.
Neutral
Zacks Investment Research
8 months ago
Should You Invest in the VanEck Biotech ETF (BBH)?
The VanEck Biotech ETF (BBH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the equity market.
Positive
Seeking Alpha
9 months ago
Why Biotech Stocks May Be Ready For A Recovery
Jared Ablass, Vice President, Portfolio Research at TD Asset Management, speaks with Greg Bonnell about how the biotech sector could benefit once rates start to come down. Why beaten down Biotech stocks could be ready for a healthy recovery.
Charts implemented using Lightweight Charts™